Description overdue on 13.10.2011

The main active ingredient - GPC - glycosaminoglycan-peptide complex . It refers to a group of active biogenic stimulators of animal origin, and has a strong chondroprotective   (protective) effect, reduces the activity of most enzymes have a devastating effect on the cartilage surface of the joint. Rumalon brakes catabolic processes It stimulates the biosynthesis mucopolysaccharides   (sulfated), improves metabolism structure hyaline tissue . The product contains a concentrated purified extract of cartilage, bone marrow, calves or other young animals. PM promotes restoration of the structure of the joint cartilage thanks to increased production of glycosaminoglycans . Collagen That serve building material. Rumalon reduces the activity and expressed the action of enzymes that destroy cartilage, stimulates the production of "grease" the joint, improves nutrition of joint cartilage. Rumalon slows the progression osteoarthritis   (thinning of the cartilage plate, changing the surface of the articular cartilage).

Dosage Form:

The solution (administered intramuscularly deep). The vials 1ml. 2 ml ampules. The package of 25 pieces.

Indications:

Various degenerative diseases of the joints: spondylosis . arthrosis . coxarthrosis . gonartroz . chondromalacia   (immobilization process of cartilage) patella . meniskopatiya   (disease of the cartilage lining the knee joint, is characterized by pain, functional impairment) spondylarthrosis .

Contraindications:

Rheumatoid arthritis , Hypersensitivity, allergic to the components. The drug is not used in pediatric practice. Among the contraindications - pregnancy, lactation. It is not recommended for use for children up to 12l.

Side effect:

Allergies (rare). Dizziness, headache, weakness, rarely - dyspepsia.

Mode of application:

Rumalon injected deep into the muscle according to the scheme: 0, 3 ml of the first day 0, 5 ml on the second day, followed by 1 ml three times a week for 6 weeks. The course of treatment - 2 times a year. In severe cases, the course can be repeated 4 times a year for many years.

Special instructions:

In some cases, there is an exacerbation of the disease during the first days of treatment. The physician must notify patients that it is a temporary phenomenon, which does not require discontinuation of therapy, it runs independently.